The American journal of gastroenterology
-
Am. J. Gastroenterol. · Jul 2017
Multicenter Study Observational StudyExtracolonic Cancer in Inflammatory Bowel Disease: Data from the GETECCU Eneida Registry.
The objective of this study was (a) To know the prevalence and distribution of extracolonic cancer (EC) in patients with inflammatory bowel disease (IBD); (b) To estimate the incidence rate of EC; (c) To evaluate the association between EC and treatment with immunosuppressants and anti-tumor necrosis factor (TNF) agents. ⋯ Neither immunosuppressants nor anti-TNF drugs seem to increase the risk of EC. Older age and smoking were associated with a higher prevalence of EC.